Fehr, C
Kokain, Amphetamin und andere Stimulantien.Holsboer F., Gründer, G., Benkert, O. (Hrsg). Handbuch der Psychopharmakotherapie. Berlin: Springer 2008
Tadic, A
Kombinationen von Antidepressivaneuro aktuell. Bd. 8. 2008 S. 28-31
Hiemke, C
Kombinationsbehandlungen in der Psychopharmakotherapie - Realität und RationalDie Psychiatrie. Bd. 5. H. 4. 2008 S. 249-254
Mann, K; Lieb, K
Kosten-Nutzen-Bewertung von ArzneimittelnInfo Neurologie & Psychiatrie. Bd. 10. H. 5. 2008 S. 38-45
Bachmann, CJ; Rieger-Gies, A; Heinzel-Gutenbrunner, M et al.
Large variability of aripiprazole and dehydroaripiprazole serum concentrations in adolescent patients with schizophreniaTher Drug Monit. Bd. 30. H. 4. 2008 S. 462-466
Dellani, PR; Eder, S; Gawehn, J et al.
Late structural alterations of cerebral white matter in long-term survivors of childhood leukemia.J Magn Reson Imaging. Bd. 27. H. 6. 2008 S. 1250-5
Kirschbaum, K; Finger, S; Vogel, F et al.
LC with Column-switching and spectrophotometric detection for determination of risperidone and 9-Hydroxyrisperidone in human serumChromatographia. Bd. 67. H. 2. 2008 S. 321-324
Stassen, HH; Anghelescu, IG; Hell, D et al.
Linking autoantibody formation to genetic vulnerability to psychiatric disorders and psychotropic drug response.Int J Neuropsychopharmacol. Bd. 11. H. s1. 2008 S. 108
Strassen, HH; Anghelescu, IG; Hell, D et al.
Linking Autoantibody Formation to Genetic Vulnerability to Psychiatric Disorders and Psychotropic Drug Response.Int J Neuropsychopharmacol. Bd. 11. H. S1. 2008 S. 108
Tadic, A
Lithium-Augmentation bei Depressionen. Erfolgreich, wenn die Gene es zulassen.InfoNeuro. Bd. 10. H. 3. 2008 S. 33-34